• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

F-FDG PET/CT在肝内胆管癌软组织转移中的应用价值:一例报告及文献复习

Application value of F-FDG PET/CT in soft tissue metastasis of intrahepatic cholangiocarcinoma: a case report and literature review.

作者信息

Liu Siwen, Sun Xiaohui, Liu Yu, Shi Ning, Zhang Xiaoli, Yu Yuechao

机构信息

Department of Nuclear Medicine, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.

出版信息

Front Oncol. 2025 Jan 16;14:1474105. doi: 10.3389/fonc.2024.1474105. eCollection 2024.

DOI:10.3389/fonc.2024.1474105
PMID:39886669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11779615/
Abstract

Intrahepatic cholangiocarcinoma (ICC)originates from the epithelial cells of the intrahepatic bile ducts, with insidious onset and strong invasiveness, and most of the cases are found in the advanced stage, with extremely poor prognosis. In advanced stages, distant metastases to the lungs, bones, and brain are common, but distant soft tissue (subcutaneous and skeletal muscle) and breast metastases are rare, and simultaneous metastases to all three rare sites had not been reported. We report a 69-year-old woman with right upper abdominal pain who underwent a plain and enhanced CT scan of the upper abdomen, which revealed an intrahepatic space-occupying lesion, as well as subcutaneous and peritoneal nodules in the abdomen. To further evaluate the presence of other metastases, an F-FDG PET/CT scan was performed, which showed abnormal FDG uptake in the liver, peritoneum, left upper femur, right breast, subcutaneous tissues of the thoracic and abdominal regions, and skeletal muscle, while the corresponding CT densities of part of the skeletal muscle and the left upper femur did not show any significant abnormality. Pathologic confirmation of ICC with multiple metastases was obtained by puncture biopsy of the liver and subcutaneous nodes. This case demonstrates the advantages of F-FDG PET/CT in comprehensively evaluating systemic metastasis of ICC and detecting occult metastases, which is of great significance in its clinical diagnosis and staging.

摘要

肝内胆管癌(ICC)起源于肝内胆管上皮细胞,起病隐匿,侵袭性强,多数病例发现时已处于晚期,预后极差。在晚期,常见远处转移至肺、骨和脑,但远处软组织(皮下和骨骼肌)及乳腺转移罕见,同时转移至这三个罕见部位的情况尚未见报道。我们报告一例69岁右上腹疼痛的女性患者,其接受了上腹部平扫及增强CT扫描,显示肝内占位性病变以及腹部皮下和腹膜结节。为进一步评估是否存在其他转移,进行了F-FDG PET/CT扫描,结果显示肝脏、腹膜、左股骨上段、右乳腺、胸腹部皮下组织及骨骼肌有异常FDG摄取,而部分骨骼肌和左股骨上段相应的CT密度未见明显异常。通过肝脏及皮下结节穿刺活检获得了ICC伴多发转移的病理证实。该病例展示了F-FDG PET/CT在全面评估ICC全身转移及检测隐匿性转移方面的优势,对其临床诊断和分期具有重要意义。

相似文献

1
Application value of F-FDG PET/CT in soft tissue metastasis of intrahepatic cholangiocarcinoma: a case report and literature review.F-FDG PET/CT在肝内胆管癌软组织转移中的应用价值:一例报告及文献复习
Front Oncol. 2025 Jan 16;14:1474105. doi: 10.3389/fonc.2024.1474105. eCollection 2024.
2
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
3
Role of [F]FAPI-04 in staging and therapeutic management of intrahepatic cholangiocarcinoma: prospective comparison with [F]FDG PET/CT.[F]FAPI-04在肝内胆管癌分期及治疗管理中的作用:与[F]FDG PET/CT的前瞻性比较
EJNMMI Res. 2024 Sep 11;14(1):81. doi: 10.1186/s13550-024-01145-y.
4
Implication of lymph node metastasis detected on 18F-FDG PET/CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma.18F-FDG PET/CT 探测到的淋巴结转移对周围型肝内胆管细胞癌患者手术规划的影响。
Clin Nucl Med. 2014 Jan;39(1):1-7. doi: 10.1097/RLU.0b013e3182867b99.
5
68 Ga-FAPI-04 PET/CT for the Evaluation of Cholangiocarcinoma : Comparison With 18 F-FDG PET/CT and Abdominal 68 Ga-FAPI-04 PET/MR.68Ga-FAPI-04 PET/CT 用于胆管癌评估:与 18F-FDG PET/CT 和腹部 68Ga-FAPI-04 PET/MR 的比较
Clin Nucl Med. 2024 May 1;49(5):409-418. doi: 10.1097/RLU.0000000000005112. Epub 2024 Mar 6.
6
Application value of F-FDG PET/CT in primary spleen angiosarcoma with liver metastasis: a case report and literature review.F-FDG PET/CT在原发性脾血管肉瘤伴肝转移中的应用价值:1例病例报告并文献复习
Front Oncol. 2024 May 24;14:1366560. doi: 10.3389/fonc.2024.1366560. eCollection 2024.
7
Detection of distant metastasis to skeletal muscle by 18F-FDG-PET in a case of intrahepatic cholangiocarcinoma.18F-FDG-PET检测肝内胆管癌病例中的骨骼肌远处转移
Korean J Hepatol. 2010 Sep;16(3):325-8. doi: 10.3350/kjhep.2010.16.3.325.
8
Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.18F-FDG PET在肝内胆管癌中的应用价值
Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1467-72. doi: 10.1007/s00259-003-1297-8. Epub 2003 Aug 7.
9
Whole-body F-fluorodeoxyglucose positron emission tomography-computed tomography (F-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India.全身 F-氟代脱氧葡萄糖正电子发射断层扫描-计算机断层扫描(F-FDG PET/CT)在局部晚期乳腺癌分期中的应用:来自印度南部一家三级癌症中心的前瞻性研究。
Indian J Med Res. 2018 Mar;147(3):256-262. doi: 10.4103/ijmr.IJMR_1368_16.
10
Comparison of PET imaging of activated fibroblasts and F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study.对比激活的成纤维细胞 PET 成像和 F-FDG 对原发性肝脏肿瘤的诊断:一项前瞻性的初步研究。
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1593-1603. doi: 10.1007/s00259-020-05070-9. Epub 2020 Oct 24.

本文引用的文献

1
F-fluorodeoxyglucose positron emission tomography/computed tomography in intrahepatic cholangiocarcinoma: could it be a new paradigm?氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在肝内胆管癌中的应用:它会成为一种新的模式吗?
Hepatobiliary Surg Nutr. 2024 Apr 3;13(2):379-381. doi: 10.21037/hbsn-23-675. Epub 2024 Mar 25.
2
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma.欧洲肝脏研究学会-国际肝脏癌症协会《肝内胆管癌管理临床实践指南》。
J Hepatol. 2023 Jul;79(1):181-208. doi: 10.1016/j.jhep.2023.03.010. Epub 2023 Apr 20.
3
Comparison of current guidelines and consensus on the management of patients with cholangiocarcinoma: 2022 update.
胆管癌患者管理的当前指南与共识比较:2022年更新
Intractable Rare Dis Res. 2022 Nov;11(4):161-172. doi: 10.5582/irdr.2022.01109.
4
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.胆道癌:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2023 Feb;34(2):127-140. doi: 10.1016/j.annonc.2022.10.506. Epub 2022 Nov 10.
5
The influence of F-fluorodeoxyglucose positron emission tomography/computed tomography on the N- and M-staging and subsequent clinical management of intrahepatic cholangiocarcinoma.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对肝内胆管癌N分期和M分期及后续临床管理的影响
Hepatobiliary Surg Nutr. 2022 Oct;11(5):684-695. doi: 10.21037/hbsn-21-25.
6
F-fluorodeoxyglucose positron emission tomography for intrahepatic cholangiocarcinoma N- and M-staging: should guidelines recommend it at last?F-氟脱氧葡萄糖正电子发射断层扫描用于肝内胆管癌的N和M分期:指南最终是否应推荐使用?
Hepatobiliary Surg Nutr. 2022 Oct;11(5):789-792. doi: 10.21037/hbsn-22-273.
7
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians.肝内胆管癌治疗进展:临床医生当前及未来治疗前景概述
CA Cancer J Clin. 2023 Mar;73(2):198-222. doi: 10.3322/caac.21759. Epub 2022 Oct 19.
8
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma.美国肝病研究学会关于原发性硬化性胆管炎和胆管癌的实践指南。
Hepatology. 2023 Feb 1;77(2):659-702. doi: 10.1002/hep.32771. Epub 2022 Oct 20.
9
Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: far from a clinical consensus.肝内胆管癌的辅助化疗:远未达成临床共识。
Hepatobiliary Surg Nutr. 2021 Dec;10(6):887-889. doi: 10.21037/hbsn-21-362.
10
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.胆管癌 2020:机制和管理的新前沿。
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. doi: 10.1038/s41575-020-0310-z. Epub 2020 Jun 30.